The t(8;21)(q22;q22) translocation mediates the expression of the fusion protein AML1‐ETO, which typically occurs in the M2 subtype of AML. Patients with t(8;21) AML have a relatively favorable prognosis, but are prone to relapse. Here, RUNX1 is linked to acute myeloid leukemia.